Pfizer CEO Albert Bourla has criticized the US government’s proposal to
lower drug prices, calling it a “negotiation with a gun to your head.” The
Biden administration has proposed allowing the government to negotiate
directly with drug companies for lower prices for Medicare, a move that has
been opposed by the pharmaceutical industry. Bourla has stated that such a
move would reduce the incentives for innovation and investment in research
and development. However, supporters of the proposal argue that it would
help lower drug prices for Americans, especially seniors who often struggle
to afford their medications.
lower drug prices, calling it a “negotiation with a gun to your head.” The
Biden administration has proposed allowing the government to negotiate
directly with drug companies for lower prices for Medicare, a move that has
been opposed by the pharmaceutical industry. Bourla has stated that such a
move would reduce the incentives for innovation and investment in research
and development. However, supporters of the proposal argue that it would
help lower drug prices for Americans, especially seniors who often struggle
to afford their medications.
